2 brands tagged as Cancer. Discover which parent companies own these brands.
Healthcare PharmaceuticalsOwned by Novartis
Prescription oncology medicine (everolimus) used to treat certain cancers and tuberous sclerosis complex, developed and marketed by Novartis AG.
Healthcare PharmaceuticalsOwned by Novartis
Prescription oncology medication for treating chronic myeloid leukemia, owned by Novartis, facing generic competition after its US patent expired in January 2024, with nilotinib generics now available in the market.